Effect of obesity on repeat revascularization in patients undergoing percutaneous coronary intervention with drug-eluting stents

Obesity

Volumn 20, Issue 1, 2012, Pages 141-146

  Wang, Zhi Jian ^a   Zhou, Yu Jie ^a   Zhao, Ying Xin ^a   Liu, Yu Yang ^a   Shi, Dong Mei ^a   Liu, Xiao Li ^a   Yu, Miao ^a   Gao, Fei ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REOPERATION; RESTENOSIS; RETROSPECTIVE STUDY; RISK REDUCTION; TARGET LESION REVASCULARIZATION;

BODY MASS INDEX; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE PROGRESSION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; OBESITY; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84655162019     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.187     Document Type: Article

References (31)

1. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097-1105. (Pubitemid 29466221)
2. Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529. (Pubitemid 29504045)
3. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-1538. (Pubitemid 29504046)
4. McGill HC Jr, McMahan CA, Herderick EE et al.; Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 2002;105:2712-2718. (Pubitemid 34615140)
5. Gruberg L, Weissman NJ, Waksman R et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002;39:578-584. (Pubitemid 34158151)
6. Gurm HS, Whitlow PL, Kip KE; BARI Investigators. The impact of body mass index on short-and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 2002;39:834-840. (Pubitemid 34185331)
7. Gurm HS, Brennan DM, Booth J et al. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol 2002;90:42-45. (Pubitemid 34671201)
8. Powell BD, Lennon RJ, Lerman A et al. Association of body mass index with outcome after percutaneous coronary intervention. Am J Cardiol 2003;91:472-476. (Pubitemid 36183574)
9. Minutello RM, Chou ET, Hong MK et al. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am J Cardiol 2004;93: 1229-1232. (Pubitemid 38595675)
10. Ellis SG, Elliott J, Horrigan M, Raymond RE, Howell G. Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol 1996;78:642-646. (Pubitemid 126658617)
11. Wang ZJ, Zhou YJ, Liu YY et al. Obesity and cardiovascular thrombotic events in patients undergoing percutaneous coronary intervention with drugeluting stents. Heart 2009;95:1587-1592.
12. Sarno G, Garg S, Onuma Y et al. The impact of body mass index on the one year outcomes of patients treated by percutaneous coronary intervention with Biolimus-and Sirolimus-eluting stents (from the LEADERS Trial). Am J Cardiol 2010;105:475-479.
13. Martin JL, Jia G, Martin SS et al. The relationship of obesity to ischemic outcomes following coronary stent placement in contemporary practice. Catheter Cardiovasc Interv 2006;67:563-570.
14. Rana JS, Mittleman MA, Ho KK, Cutlip DE. Obesity and clinical restenosis after coronary stent placement. Am Heart J 2005;150:821-826. (Pubitemid 41396521)
15. Nikolsky E, Kosinski E, Mishkel GJ et al. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial). Am J Cardiol 2005;95:709-715. (Pubitemid 40332647)
16. Ferro-Luzzi A, Garza C, Haas J et al. Physical status: the use interpretation of anthropometry: report of a WHO Expert Committee. WHO Tech Rep Ser 1995;854:1-452.
17. Lagerqvist B, James SK, Stenestrand U et al.; SCAAR Study Group. Longterm outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356:1009-1019. (Pubitemid 46376801)
18. Song YB, Hahn JY, Choi SH et al. Sirolimus-versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry. J Am Coll Cardiol 2010;55: 1743-1750.
19. Urban P, Abizaid A, Banning A et al.; e-SELECT Investigators. Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registry. J Am Coll Cardiol 2011;57:1445-1454.
20. Shubair MM, Prabhakaran P, Pavlova V et al. The relationship of body mass index to outcomes after percutaneous coronary intervention. J Interv Cardiol 2006;19:388-395. (Pubitemid 44511068)
21. Wee CC, Girotra S, Weinstein AR, Mittleman MA, Mukamal KJ. The relationship between obesity and atherosclerotic progression and prognosis among patients with coronary artery bypass grafts the effect of aggressive statin therapy. J Am Coll Cardiol 2008;52:620-625.
22. Rodés-Cabau J, Facta A, Larose E et al. Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting. Am J Cardiol 2007;100:640-645. (Pubitemid 47223143)
23. Nicholls SJ, Tuzcu EM, Sipahi I et al. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis. JAMA 2007;297:499-508. (Pubitemid 46220805)
24. Anderson JL, Horne BD, Jones HU et al.; Intermountain Heart Collaborative (IHC) Study. Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease? Cardiology 2004;101:185-193. (Pubitemid 38314632)
25. Marroquin OC, Kip KE, Kelley DE et al.; Women's Ischemia Syndrome Evaluation Investigators. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 2004;109:714-721. (Pubitemid 38222889)
26. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-2135.
27. Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res 2004;12:180-186. (Pubitemid 41132540)
28. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978. (Pubitemid 29177345)
29. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000;148:209-214. (Pubitemid 30064452)
30. Zhou BF; Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 2002;15:83-96.
31. Razak F, Anand S, Vuksan V et al.; SHARE Investigators. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) 2005;29:656-667. (Pubitemid 40769487)